This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: True Health IP LLC. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: **Erin Grace Summers Bellin: Innovating Cardiovascular Diagnostics**
Introduction
Erin Grace Summers Bellin, located in Sandston, VA, is a distinguished inventor renowned for her contributions to the field of cardiovascular diagnostics. With a focus on innovative methodologies, she has developed patent-protected technologies that aim to enhance the understanding and measurement of lipoprotein(a), a significant biomarker related to cardiovascular risk.
Latest Patents
Erin holds a patent titled "Lp(a) subform size identification using ELISA." This pioneering invention outlines methods for determining the particle number and/or molar mass of lipoprotein(a) subforms in biological samples utilizing enzyme-linked immunosorbent assay (ELISA). Her technology significantly improves existing lipoprotein ELISA methods and introduces devices capable of quantitatively measuring particle numbers and population mass of Lp(a) particles. This advancement provides a rapid, efficient, and cost-effective means for accurately assessing specific Lp(a) levels, transcending traditional measurement limitations often faced in patient tissues. Ultimately, her methodology serves as a critical diagnostic tool for evaluating cardiovascular risk in subjects.
Career Highlights
Erin's career is marked by her commitment to advancing medical technology through innovative inventions. Her patent reflects a deep understanding of cardiovascular health, emphasizing the importance of specific and accessible diagnostic tools in the medical field. By improving ELISA methods, she not only enhances research capabilities but also contributes to better patient care through more accurate assessments.
Collaborations
Throughout her professional journey, Erin has collaborated with several colleagues, including Philip A. Guadagno and Daniel M. Hoefner. These collaborations have fostered a shared vision of advancing health diagnostics and have played a vital role in the development of her groundbreaking patent.
Conclusion
Erin Grace Summers Bellin exemplifies the spirit of innovation in the medical field. Her dedication to improving cardiovascular diagnostics through her patented methodologies has the potential to revolutionize the way lipoprotein(a) is measured and understood. As her work continues to influence the healthcare landscape, Erin remains a pivotal figure in the pursuit of better diagnostic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile